Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Healthcare product developer PuraMed BioScience has plans to expand the retail sales efforts of its OTC migraine product LipiGesic M to an additional 21,000 retail outlets.
Subscribe to our email newsletter
The retail outlets include mass merchandisers such as Wal-Mart and Target, food store chains such as SuperValu, Kroger and Safeway, and regional drugstores.
These retailers were selected according to various material criteria such as cost of entry, geography, demographics and consumer preference.
The company plans on embarking on a national marketing campaign to promote, increase distribution for LipiGesic M to support its retail expansion effort.
Recently, LipiGesic M has been confirmed as an over-the-counter medication for the treatment of acute migraine pain.
LipiGesic M is stocked in 15,000 stores including in some of the largest drug store chains in the US, such as Walgreen’s and CVS Pharmacy.